AC
HAE icon

Armistice Capital’s Haemonetics HAE Stock Holding History

Armistice Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-872,000
Closed -$46.3M – 156
2021
Q4 		$46.3M Buy
872,000
+122,000
+16% +$7.43M 0.76% 33
2021
Q3 		$52.9M Buy
750,000
+126,000
+20% +$7.95M 0.9% 25
2021
Q2 		$41.6M Buy
+624,000
New +$44.2M 0.74% 34

Other funds holding HAE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Armistice Capital's HAE Position: Q1 2022 in Review

Armistice Capital sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 872,000 shares — an estimated $46.3M sold.

Armistice Capital first reported a position in HAE in Q2 2021 and held it in 3 quarters. The position peaked at $52.9M in Q3 2021. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • Armistice Capital reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
  • Armistice Capital sold 872,000 Haemonetics shares in Q1 2022, an estimated $46.3M.
  • Armistice Capital first reported a position in Haemonetics in Q2 2021 and held it in 3 quarters.
  • Armistice Capital's Haemonetics position peaked at $52.9M in Q3 2021.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.